U.S. Markets open in 2 hrs, 48 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,318.16 | -14.28 | -0.14% |
| NASDAQ | 2,146.04 | -10.78 | -0.50% |
| S&P 500 | 1,091.38 | -3.52 | -0.32% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 35.64 09:30 AM EST | |
|---|---|---|
| Day High | 36.56 03:30 PM EST |
|
| Range | 0.92 |
| Volume | 115,086 | |
|---|---|---|
| 30-Day Avg Vol | 168,000 |
|
| Difference | -31.50% |
| Market Cap | 625.83 M | |
|---|---|---|
| Mkt Cap Chg | 9.95 M |
| Shares Out | 17.16 M | |
|---|---|---|
| % Shrs Traded | 0.67% | |
| 1yr EPS Est | 1.707 |
| 52-Wk Low | 24.15 | |
|---|---|---|
| 52-Wk High | 37.24 |
|
| Range | 13.09 |
| Prev Close | 35.88 11/19/09 | |
|---|---|---|
| Today's Open | 35.64 | |
| Change | -0.67% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.19 M |
| Revenue (LFY) | 116.17 M | |
|---|---|---|
| Earnings (LFY) | 31.36 M | |
| Earnings (MRQ) | 9.46 M | |
| Next Earn Est | 0.337 | |
| Next Earnings | 11/05/2009 |
|
| EPS (TTM) | 1.60 | |
| 1yr EPS Growth | 6.69% |
| P/E Ratio (TTM) | 22.79 | |
|---|---|---|
| P/E Ratio (Fwd) | 21.00 | |
| PEG Ratio | 0.81 | |
| Return on Equity | 26.14 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Health Services |
above for more info
Genoptix is promoting optimal cancer diagnostics. The biotechnology company is a specialized laboratory service provider founded in 1999. It analyzes blood and tissue samples in order to diagnose and monitor ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.337 N/A | — — |
—
—
|
| Last Quarter | 0.342 9/30/09 | 0.53 9/30/09 |
0.188
Beat
|
| 2 Quarters Ago | 0.312 6/30/09 | 0.44 6/30/09 |
0.128
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 50.81 M | 116.17 M |
| Gross Profit | 32.40 M | 70.24 M |
| Operating Income | 16.38 M | 26.63 M |
| Net Income | 9.46 M | 31.36 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts